Fig. 3. (A ) Fentanyl, 10 μm (black bars ), does not evoke inward currents in NR1A/2A or NR1A/2B N -methyl-d-aspartate receptors, in contrast to glutamate 1 mm/glycine EC50(glu/gly) (white bars ) (n = 10; vertical bars ± SEMs). (B ) Application of Ultiva®(0.1 mm remifentanil plus 3.1 mm glycine) after 10 min incubation in naloxone (0.1 mm; white bar ) does not abolish Ultiva®-evoked N -methyl-d-aspartate receptor currents (NR1A/2A) (n = 10; vertical bars ± SEMs).

Fig. 3. (A ) Fentanyl, 10 μm (black bars ), does not evoke inward currents in NR1A/2A or NR1A/2B N -methyl-d-aspartate receptors, in contrast to glutamate 1 mm/glycine EC50(glu/gly) (white bars ) (n = 10; vertical bars ± SEMs). (B ) Application of Ultiva®(0.1 mm remifentanil plus 3.1 mm glycine) after 10 min incubation in naloxone (0.1 mm; white bar ) does not abolish Ultiva®-evoked N -methyl-d-aspartate receptor currents (NR1A/2A) (n = 10; vertical bars ± SEMs).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal